XML 35 R18.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Note 13 - Equity
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Equity [Text Block]

13. Equity

 

The tables below present changes in stockholders' equity for the three and six months ended June 30, 2024 and 2023.

 

  

Common Stock

  

Additional Paid-in

  

Accumulated

  

Other Comprehensive

  

Total Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Equity

 

Balances at March 31, 2024

  71,122,516  $7,112  $236,766,447  $(71,783,354) $  $164,990,205 

Net income

           1,832,616      1,832,616 

Payment of common stock tendered for employee stock-based compensation tax obligations

  (25,669)  (2)  (196,556)        (196,558)

Issuance of common stock upon vesting of RSUs

  209,046   21   (21)         

Stock-based compensation

        932,286         932,286 

Balances at June 30, 2024

  71,305,893  $7,131  $237,502,156  $(69,950,738) $  $167,558,549 

 

  

Common Stock

  

Additional Paid-in

  

Accumulated

  

Other Comprehensive

  

Total Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Equity

 

Balances at December 31, 2023

  71,091,616  $7,109  $235,795,420  $(38,943,622) $  $196,858,907 

Net income

           12,109,956      12,109,956 

Issuance of common stock

  49,940   5   (5)         

Payment of common stock tendered for employee stock-based compensation tax obligations

  (44,709)  (4)  (355,535)        (355,539)

Issuance of common stock upon vesting of RSUs

  209,046   21   (21)         

Cash dividend ($0.60 per share)

           (43,117,072)     (43,117,072)

Stock-based compensation

        2,062,297         2,062,297 

Balances at June 30, 2024

  71,305,893  $7,131  $237,502,156  $(69,950,738) $  $167,558,549 

 

  

Common Stock

  

Additional Paid-in

  

Accumulated

  

Other Comprehensive

  

Total Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Equity

 

Balances at March 31, 2023

  71,535,268  $7,154  $234,366,497  $(72,280,191) $  $162,093,460 

Net loss

           (2,875,476)     (2,875,476)

Repurchase of common stock (including excise tax)

  (596,900)  (60)     (3,515,396)     (3,515,456)

Issuance of common stock upon vesting of RSUs

  144,576   15   (15)         

Payment of common stock tendered for employee stock-based compensation tax obligations

        (214,794)        (214,794)

Cash dividend ($0.45 per share)

           (32,135,118)     (32,135,118)

Stock-based compensation

        721,440         721,440 

Balances at June 30, 2023

  71,082,944  $7,109  $234,873,128  $(110,806,181) $  $124,074,056 

 

  

Common Stock

  

Additional Paid-in

  

Accumulated

  

Other Comprehensive

  

Total Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Income

  

Equity

 

Balances at December 31, 2022

  72,675,190  $7,268  $233,957,767  $(63,804,993) $  $170,160,042 

Net loss

           (3,793,733)     (3,793,733)

Repurchase of common stock (including excise tax)

  (1,736,822)  (174)     (11,072,337)     (11,072,511)

Issuance of common stock upon vesting of RSUs

  144,576   15   (15)         

Payment of common stock tendered for employee stock-based compensation tax obligations

        (214,794)        (214,794)

Cash dividend ($0.45 per share)

           (32,135,118)     (32,135,118)

Stock-based compensation

        1,130,170         1,130,170 

Balances at June 30, 2023

  71,082,944  $7,109  $234,873,128  $(110,806,181) $  $124,074,056 

 

On August 2, 2021, the Company's Board of Directors authorized a share repurchase program ("Repurchase Authorization") under which the Company could repurchase up to $50 million of the Company's common stock through December 31, 2023. The Company started repurchasing shares under this program in the fourth quarter of 2021. Repurchases under the Repurchase Authorization were made from time to time at the Company's discretion. The timing and actual number of shares repurchased depended on a variety of factors, including: timing of procurement orders under government contracts; alternative opportunities for strategic uses of cash; the stock price of the Company’s common stock; market conditions; alternative capital management uses of cash; and other corporate liquidity requirements and priorities. On December 31, 2023, the Repurchase Authorization expired. As a result, during the three and six months ended June 30, 2024, the Company did not repurchase any shares. During the three and six months ended June 30, 2023, the Company repurchased approximately 0.6 million and 1.7 million shares of common stock under the Repurchase Authorization for approximately $3.5 million and $11.0 million, respectively. In addition, during the three and six months ended June 30, 2023, the Company recorded approximately $0.1 million of excise tax associated with the repurchase of common stock.

 

On March 12, 2024, the Board of Directors declared a special dividend of $0.60 per share on the common stock of the Company, which resulted in an overall dividend payment of approximately $43 million. The special dividend was paid on April 11, 2024 to shareholders of record at the close of business on March 26, 2024.